FDA Clearance Tracker · P990040-S030
TRUFILL n-BCA Liquid Embolic System
Last checked: Nov 20, 2026Latest source record: Feb 28, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Feb 28, 2023
Approved
Time to decision
103 days
Received Nov 17, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P990040-S030
- Device name
- TRUFILL n-BCA Liquid Embolic System
- Applicant
- Cerenovus, Inc.
- Applicant location
- Miami, FL
- Received
- Nov 17, 2022
- Decided
- Feb 28, 2023
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P990040
Device type
- Device class
- Class III
- Specialty
- Neurology & Neurosurgery
FDA's approval statement
As written in FDA's record.
Approval for new manufacturing sites located at: 1) Steris Isomedix Services, 1175 Isuzu Parkway, Grand Prairie, Texas, 75050; 2) Steris Isomedix Services, 7685 St. Andrews Avenue, San Diego, California, 92154; and 3) Sterigenics, 2400 Airport Road, Santa Teresa, New Mexico, 88008. These manufacturing sites will be performing sterilization of the TRUFILL n-BCA Liquid Embolic System.
Source documents
Other decisions for Cerenovus, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K262419 · Decided Aug 14, 2026 · 30 days after receipt
Device type: Device, Neurovascular Embolization (HCG) · Neurology & Neurosurgery
K262398 · Decided Aug 13, 2026 · 30 days after receipt
Device type: Catheter, Thrombus Retriever (NRY) · Cardiology
- TRUFILL n-BCA Liquid Embolic System (LES), TRUFILL n-BCA Liquid Embolic System Procedural SetPMA supplement
P990040-S034 · Decided Dec 16, 2025 · 316 days after receipt · Panel Track
Device type: Neurovascular Liquid Embolic Agent (SGU) · Neurology & Neurosurgery
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.